1-15 of 479

GLP-1 Receptor Agonists in Stroke Prevention: Evidence of Ischemic Benefit
Clinician's RoundtableGLP-1 Receptor Agonists in Stroke Prevention: Evidence of Ischemic Benefit

Metabolic Rewiring in DKD: The Role of Tubular Cells
Clinician's RoundtableMetabolic Rewiring in DKD: The Role of Tubular Cells

Exploring Drivers of DKD: Metabolic Rewiring and Mitochondrial Dysfunction
Clinician's RoundtableExploring Drivers of DKD: Metabolic Rewiring and Mitochondrial Dysfunction

Rethinking CKD Screening in the Era of New Therapies
Heart MattersRethinking CKD Screening in the Era of New Therapies

Who Should Be Tested for Chronic Kidney Disease?
Heart MattersWho Should Be Tested for Chronic Kidney Disease?

Screening for Significant Fibrosis in Patients with Obesity
GI InsightsScreening for Significant Fibrosis in Patients with Obesity
- advertisement

Obesity and Liver Disease: Getting to the Core of Treatment
GI InsightsObesity and Liver Disease: Getting to the Core of Treatment

Is Lifestyle Intervention Enough for Obesity and MASLD?
GI InsightsIs Lifestyle Intervention Enough for Obesity and MASLD?

A Patient-Centered Approach to Obesity Management
Clinician's RoundtableA Patient-Centered Approach to Obesity Management

The Emerging Role of Triple Agonists in Obesity Management
Clinician's RoundtableThe Emerging Role of Triple Agonists in Obesity Management

Treating Obesity Today: GLP-1s, Surgery, and Beyond
GI InsightsTreating Obesity Today: GLP-1s, Surgery, and Beyond
- advertisement

Personalizing Nutrition and Exercise Alongside GLP-1 Receptor Agonist Therapy
Diabetes DiscoursePersonalizing Nutrition and Exercise Alongside GLP-1 Receptor Agonist Therapy

UACR in Diabetes: A Window Into Cardiorenal Risk
Diabetes DiscourseUACR in Diabetes: A Window Into Cardiorenal Risk

Maintaining Weight Loss: Early Evidence on Microbiome-Derived Supplementation
NutritionEdgeMaintaining Weight Loss: Early Evidence on Microbiome-Derived Supplementation








































